Healthcare giant Medline files to return to public markets via Nasdaq listing By Investing.com
Update: 2025-10-29
Description
Medline, a leading healthcare products manufacturer and distributor, has filed for an initial public offering (IPO) on the Nasdaq Global Select Market, using the ticker symbol MDLN. The company reported impressive financials for the quarter ending June 2025, with net sales of $6.89 billion and net income of $333 million. However, details such as the number of shares and price range are still uncertain, and the IPO's approval and timing depend on market conditions. Big-name financial institutions like Goldman Sachs, Morgan Stanley, BofA Securities, and J.P. Morgan are involved, indicating strong interest. This IPO is notable as Medline went private in 2021 and is now considering a return to the public market.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
